FILE:CAH/CAH-8K-20120731072553.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( General Instruction A.2. below):
see
 
 
 
 
 
 
 
Item 7.01 Regulation FD Disclosure
In connection with the combined pharmaceutical distribution request for proposal issued following its merger with Medco Health Solutions, Inc., Express Scripts, Inc. has informed Cardinal Health, Inc. (the "Company") that it has decided not to renew its pharmaceutical distribution agreement with the Company. That agreement expires on September 30, 2012 and has provided approximately $9 billion of annual revenue to the Company, all of which is classified as bulk sales.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 


